ETHZilla Corporation Warrant
NASDAQ: ATNFW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Lloyd Blair Jordan
- Employees
- 4
- Headquarters
- Palo Alto, United States
- IPO year
- 2017
- Market cap
- $2.6M
- Website
- http://www.180lifesciences.com
Loading ATNFW…
Loading profile data…Frequently asked questions about ATNFW
What does ETHZilla Corporation Warrant (ATNFW) do?
180 Life Sciences Corp. is a biotechnology firm currently in the clinical trial phase, dedicated to pioneering novel pharmaceutical treatments that address significant unmet medical needs in areas such as inflammatory conditions, fibrotic disorders, and pain management. This research and development effort is powered by the collective expertise...
Where does ATNFW trade?
ETHZilla Corporation Warrant (ATNFW) trades on the NASDAQ Capital Market.
What sector is ATNFW in?
ETHZilla Corporation Warrant (ATNFW) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of ETHZilla Corporation Warrant?
Lloyd Blair Jordan is the chief executive officer of ETHZilla Corporation Warrant (ATNFW).
Where is ETHZilla Corporation Warrant headquartered?
ETHZilla Corporation Warrant is headquartered in United States.
Does ATNFW pay a dividend?
ETHZilla Corporation Warrant (ATNFW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATNFW go public?
ETHZilla Corporation Warrant (ATNFW) completed its initial public offering in 2017.